Veracyte Inc risk profile
40 Elevated one input has moved against it
Measured 21 October 2026 from VCYT's filed statements. Recomputed nightly.
40 (Elevated), driven by Concentration at 95, over 7 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 61 | Stretched | Volatile | One-year price volatility — 64.7% |
| Operating pressure | 1 | Contained | Stable | Input-cost exposure — 0.01 |
| Cash conversion | 11 | Contained | Stable | Capital spending against operating cash — 0.07x |
| Leverage and coverage | 0 | Contained | Stable | Net debt to EBITDA — -4.08x |
| Competitive position | 38 | Normal | Stable | Operating-margin gap against peers — +3.6 percentage points |
| Concentration | 95 | Acute | Stable | Geographic concentration — 9,221 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.